Pricing Log in Create free account

Alto Neuroscience, Inc. (ANRO) vs Jade Biosciences, Inc. (JBIO)

Alto Neuroscience, Inc. and Jade Biosciences, Inc. are both Biotechnology companies. Alto Neuroscience, Inc. and Jade Biosciences, Inc. are of similar size ($887.7M and $875.1M). Across the 9 metrics below, Jade Biosciences, Inc. leads on 6 and Alto Neuroscience, Inc. on 3.

Valuation

Metric ANRO JBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 4.31 1.87 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.97%) (14.23%) (33.15%)
Free cash flow yield (7.29%) (15.03%) (25.50%)

Profitability

Metric ANRO JBIO Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.17%) (39.27%) (56.36%)
Return on assets (40.90%) (36.19%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANRO JBIO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 12.40% 78.57% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANRO JBIO Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 14.85 14.93 4.72
Net debt to EBITDA 2.40 2.94 0.96

Dividend

Metric ANRO JBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANRO JBIO Biotechnology median
Market cap 887.66m 875.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack